All stocks / PBSV
Pharma-Bio Serv, Inc. PBSV
Pharma-Bio Serv (PBSV): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- PHARMA-BIO SERVICES INC
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 13
News headlines
The financial report, and what it means
Annual figures to 2025-10-31- Revenue
- $9,001,096
- Net loss
- ($100,463)
It spends more than it earns
Under strainCustomers paid it $9 million in the year. It lost $100,463. For every $1 that came in, about $1.01 went out.
- Cash and cash equivalents
- $3,379,212
- Net cash used in operating activities
- ($214,886)
It has cash for a while
SteadyIt had $3.4 million in the bank and used about $17,907 a month. At that pace the money lasts about 189 months unless it borrows or sells more shares.
- Total assets
- $13,653,046
- Total liabilities
- $1,738,799
It owns more than it owes
SteadyEverything the company owns adds up to $13.7 million. Its debts and unpaid bills add up to $1.7 million. That is about $0.13 owed for every $1 owned.
What this adds up to
1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 22,901,692 shares as of 2026-09-10: 22,901,692 outstanding minus 0 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about PBSV
Does PBSV file reports with the SEC?
Yes. Pharma-Bio Serv files with the SEC under company number 0001304161. The most recent filing we hold is a 10-Q dated 2026-09-14.
Source recordHow many PBSV shares are outstanding?
22,901,692 shares as of 2026-09-10, as reported to the SEC.
Source recordHas PBSV filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Who runs Pharma-Bio Serv?
Officers named in its insider filings: Kirk Wheeler Michel (Chairman).
Source recordIs Pharma-Bio Serv making money?
Customers paid it $9 million in the year. It lost $100,463. For every $1 that came in, about $1.01 went out. (Annual figures to 2025-10-31. Facts from the company's own report, not a recommendation.)
Source record